Tamoxifen to prevent cancer in pancreatic cysts
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether tamoxifen, a hormone-blocking pill, can prevent pancreatic cysts from turning into cancer in people who are not having surgery to remove the cyst right away.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have a type of pancreatic cyst called a mucinous cystic neoplasm (MCN) that is not cancerous and is not being removed right away
- You have not taken tamoxifen or similar drugs in the past 5 years
- You have not had a blood clot, stroke, or certain eye or uterine conditions
- You are willing to use two forms of birth control if you or your partner could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects pancreatic cyst fluid or tissue to study the genes of these tumors. The goal is to better understand pancreatic cysts and improve future treatments.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This trial tests whether tamoxifen, a hormone therapy drug, can shrink or slow down advanced solid pseudopapillary tumors of the pancreas (SPTP) that have estrogen and progesterone receptors. It may be an option for people whose tumors cannot be removed by surgery or have come back after other treatments.
This study tests whether tamoxifen, a medicine usually used for breast cancer, is safe for adults with cystic fibrosis who cannot take CFTR modulators. It aims to see if tamoxifen can be a new treatment option.
This trial tests a new method using an endoscope (a thin tube with a camera) to deliver a chemotherapy drug directly into a pancreatic cyst called IPMN. The goal is to see if this approach is safe and can prevent the cyst from growing or turning into cancer.
Hear when a new Pancreatic Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.